HIV Clinical Trial
Official title:
Preliminary Field Evaluation of a Point-of-Care Transaminase Test
The proposed preliminary field evaluation will compare a point-of-care (POC) transaminase test with the standard of care test used in an HIV clinic at the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam.
The DFA transaminase test provides rapid categorical measurement of ALT in a whole blood
specimen taken via finger-stick. The test is based on the platform technology of "paper
microfluidics" (also known as "patterned paper"), in which hydrophobic barriers are
patterned into a sheet of paper in order to create microfluidic, hydrophilic paths within
the paper, through which flow can be directed towards specific detection zones. The test is
designed for visual color-coded readout in three ALT ranges ("bins") that correspond to the
ranges of AST and ALT (<3x the upper limit of normal (ULN), 3-5x ULN, and >5x ULN) currently
used for clinical management decisions per US TB and HIV treatment guidelines. The bin
cutoffs are common to treatment guidelines used around the globe, including those used by
the Vietnam Ministry of Health.
The colorimetric readout is designed to be read by eye using a visual "read guide" allowing
the reader to make a semi-quantitative estimate or assign a categorical value into one of
three bins. Alternatively, if the device is scanned (e.g. desk-top scanner) or photographed
(e.g. cell phone or standard digital camera, see (9)) and read with image-analysis software,
it should be possible to generate a quantitative result. Additionally, multiple control
zones notify the user of insufficient sample volume, hemolysis, or damaged reagents.
The overall goal of this study is to conduct a preliminary field evaluation of an
investigational transaminase test in a population at risk for DILI. The primary objectives
are:
1. Determine device accuracy by measuring the percent agreement of the categorical visual
readout DFA transaminase test and the standard of care tests used in the HTD HIV
clinic.
2. Determine inter-operator variability.
3. Determine device failure rate as defined by invalid test results.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |